How should pruritus be assessed and managed, including classification, history taking, investigative work‑up, and treatment options?

Pruritus: Etiology, Investigation, History, and Treatment

Etiology and Classification

Pruritus without visible dermatosis can be systematically classified into four major categories: systemic disease-related (15%), neuropathic (25%), inflammatory (60%), and generalized pruritus of unknown origin (GPUO). 1, 2, 3

Key Systemic Causes to Identify:

• Iron deficiency accounts for approximately 25% of generalized pruritus cases and resolves completely within days of iron replacement 2
• Cholestatic liver disease presents characteristically with palm/sole predominance and nocturnal worsening 1, 2
• Chronic kidney disease/uremia correlates with disease severity and is a well-established cause 1, 2
• Hematologic disorders including polycythemia vera (aquagenic pruritus), Hodgkin's lymphoma, and solid tumors 1, 2
• Drug-induced pruritus occurs in 12.5% of drug reactions, particularly opioids 1, 2
• Endocrine disorders (thyroid disease, diabetes), HIV/hepatitis infections 1, 2

Neuropathic Causes:

• Localized neuropathic pruritus includes notalgia paresthetica, brachioradial pruritus, postherpetic neuralgia 4, 3, 5
• Small fiber neuropathy may present as generalized pruritus 2

Psychogenic Pruritus:

• Requires three compulsory criteria: pruritus sine materia, chronicity >6 weeks, and absence of somatic cause 6
• Must have 3 of 7 additional criteria: chronological relationship with life events, stress variation, nocturnal variation, predominance during rest, associated psychological disorders, improvement with psychotropics, or improvement with psychotherapy 6

---

History Taking: Critical Elements

Onset and Temporal Pattern:

• Duration: Chronic pruritus is defined as ≥6 weeks 3, 7
• Time of day: Nocturnal worsening suggests cholestatic disease 1, 2
• Relationship to water exposure: Aquagenic pruritus indicates polycythemia vera 2
• Relationship to salt intake: Worsening with sodium suggests fluid retention from kidney, liver, or heart disease 2

Distribution Pattern:

• Generalized vs. localized: Localized suggests neuropathic cause; generalized suggests systemic disease 4, 5
• Palm and sole predominance: Strongly suggests cholestatic liver disease 1, 2
• Fixed anatomic location: Indicates neuropathic etiology 4, 5

Medication History:

• Complete review of all medications including over-the-counter and herbal products is mandatory, as drug-induced pruritus is common and reversible 2
• Recent opioid use (postoperative, chronic pain management) 1
• Statins (rosuvastatin causes cholestatic hepatitis in 1.1% of patients) 2
• Chloroquine exposure 1

Associated Symptoms:

• Jaundice, dark urine, pale stools: Cholestatic disease 2
• Fatigue, weakness: Iron deficiency, anemia 2
• Weight loss, night sweats: Malignancy 2
• Polyuria, polydipsia: Diabetes, renal disease 2

Risk Factors:

• Travel history: HIV, hepatitis, parasitic infections 1, 2
• Pregnancy status: Intrahepatic cholestasis of pregnancy 2
• Age >65 years: Pruritus in elderly skin, increased malignancy risk 1
• Psychological stressors: Temporal relationship with life events 6

---

Investigation: Systematic Diagnostic Workup

Mandatory Initial Laboratory Panel (All Patients):

Order these tests immediately for all patients with chronic generalized pruritus without rash: 1, 2, 8

• Complete blood count with differential: Screen for polycythemia vera, lymphoma, anemia 1, 2
• Comprehensive iron studies (serum iron, ferritin, transferrin saturation): Iron deficiency is the single most common treatable cause 2, 8
• Liver function tests, total bilirubin, serum bile acids: Identify cholestatic disease 1, 2, 8
• Renal panel (urea, creatinine, electrolytes): Detect uremic pruritus 1, 2, 8
• Erythrocyte sedimentation rate: General inflammatory marker 8

Conditional Testing Based on History:

• Thyroid-stimulating hormone: Only if clinical features suggest thyroid dysfunction 1, 2
• JAK2 V617F mutation: If aquagenic pruritus suggests polycythemia vera 1, 2
• HIV and hepatitis A, B, C serologies: With appropriate travel or risk history 1, 2
• Chest radiograph: Only if systemic features raise suspicion for lymphoma, not routinely 2
• Antimitochondrial antibodies: When cholestatic liver tests suggest primary biliary cholangitis 2

Second-Tier Investigations (If Initial Workup Unrevealing):

• Skin biopsy: For persistent unexplained pruritus to evaluate cutaneous lymphoma or small fiber neuropathy 1, 2
• Imaging studies: Only with specific clinical indications, not routine screening 2

Critical Pitfall to Avoid:

Do not rely on ferritin alone—comprehensive iron studies are essential to avoid missing iron deficiency cases. 2 Do not order extensive endocrine panels, routine chest X-rays, or malignancy screens without specific clinical indicators. 1, 2

---

Treatment Approach: Algorithmic Management

Universal First-Line Treatment (All Patients, Immediately):

Begin emollients and moisturizers liberally (at least twice daily) while awaiting diagnostic results—this is first-line therapy for all pruritus regardless of cause. 1, 2, 8

• Apply high-lipid content moisturizers, particularly in elderly patients 1, 8
• Provide self-care advice: keep nails short, avoid hot water, reduce stress 1, 8

Symptomatic Treatment (While Investigating):

• Non-sedating antihistamines: Fexofenadine 180 mg or loratadine 10 mg daily 1, 8
• Mildly sedative option: Cetirizine 10 mg if sleep disruption is significant 1
• Avoid sedating antihistamines (hydroxyzine) long-term due to dementia risk in elderly 2

Topical Therapies for GPUO:

• Topical doxepin: Limited to 8 days, 10% body surface area, 12 g daily maximum 1, 8
• Topical clobetasone butyrate or menthol: May provide benefit 1, 8
• Refrigerated menthol and pramoxine: For symptomatic relief 2, 3
• Avoid crotamiton cream, capsaicin, and calamine lotion: Not effective 1

---

Cause-Specific Treatment Algorithms

Iron Deficiency Pruritus:

Oral iron replacement leads to complete cessation of pruritus within days of initiation—this is the most rapidly effective treatment when iron deficiency is identified. 2, 8

Uremic Pruritus (Chronic Kidney Disease):

First-line pharmacologic therapy: 1, 2

• Broadband UVB phototherapy: Most effective treatment (Level 1+ evidence) 1, 2
• Optimize dialysis adequacy: Ensure Kt/V ≥1.6 (relieves pruritus in 40% of patients) 2

Second-line systemic therapy: 1, 2, 8

• Gabapentin 300-1200 mg daily in divided doses 1, 2, 8

Alternative options: 1

• Auricular acupressure or aromatherapy 1
• Renal transplantation is the only definitive cure 1

Hepatic/Cholestatic Pruritus:

Treatment hierarchy: 1, 2, 8

1. First-line: Rifampin 150 mg twice daily (Strength of recommendation A) 1, 2, 8
2. Second-line: Cholestyramine 9 g daily 1, 2, 8
3. Third-line: Sertraline 1
4. Fourth-line: Naltrexone or nalmefene 1
5. Fifth-line options: Dronabinol, phenobarbital, propofol, topical tacrolimus 1

Phototherapy option: 1

• Broadband UVB or combined UVA/UVB may relieve cholestatic itch 1

Critical pitfall: Do not use gabapentin for hepatic pruritus—it is ineffective. 2

Drug-Induced Pruritus:

Opioid-induced pruritus: 1

• First-choice: Naltrexone (if cessation of opioid impossible) (Strength of recommendation B) 1
• Alternatives: Methylnaltrexone, ondansetron, droperidol, mirtazapine, gabapentin 1

Postoperative pruritus: 1

• Diclofenac 100 mg rectally 1

Chloroquine-induced pruritus: 1

• Prednisolone 10 mg, niacin 50 mg, or combination 1
• Dapsone as alternative 1

Polycythemia Vera-Associated Pruritus:

• Cytoreductive therapy, low-dose aspirin, interferon-α, selective serotonin reuptake inhibitors, or narrow-band UVB phototherapy 2

Lymphoma-Associated Pruritus:

Pharmacologic options: 2

• Cimetidine, carbamazepine, gabapentin, mirtazapine, oral corticosteroids (for incurable disease) 2

Phototherapy: 2

• Broadband UVB for Hodgkin lymphoma 2
• Narrow-band UVB for non-Hodgkin lymphoma 2

Neuropathic Pruritus:

Topical agents: 3

• Menthol, pramoxine, or lidocaine (alone or combined with topical steroids) 3

Systemic agents: 1, 3

• Gabapentin, pregabalin 1, 3
• Antidepressants: sertraline, doxepin 3
• Opioid receptor agonist/antagonists: naltrexone, butorphanol 3

Referral: 1

• Refer to relevant specialist (neurology, pain management) for treatment 1

Psychogenic Pruritus:

Behavioral interventions: 1

• Education on trigger avoidance, lifestyle interventions, relaxation techniques, cognitive restructuring, habit reversal training 1
• Patient support groups 1
• Referral to social workers, liaison psychiatry, psychologists 1

Pharmacologic options: 2, 6

• Psychotropic drugs may improve symptoms 6
• Narrow-band UVB phototherapy 1

---

Refractory Pruritus: Second-Line Systemic Therapies

If no improvement after 2-4 weeks of first-line treatment, consider: 1, 2, 8

• Antidepressants: Paroxetine, fluvoxamine, mirtazapine 1, 2, 8
• Neuropathic agents: Gabapentin or pregabalin (avoid in hepatic disease) 1, 2, 8
• Opioid antagonists: Naltrexone, butorphanol 1, 2
• Anti-emetics: Ondansetron, aprepitant 1, 2
• H1 and H2 antagonist combination: Fexofenadine plus cimetidine 1

For severe refractory cases: 2

• Dupilumab or methotrexate (requires dermatology referral) 2, 3

---

Alternative and Adjunctive Therapies

• Acupuncture: Consider as monotherapy or combined with Chinese herbal remedies as second-line option 1, 8
• Transcutaneous electrical nerve stimulation: May benefit hepatic pruritus 1
• Stress reduction techniques: Cognitive behavioral therapy, habit reversal training to break itch-scratch cycle 2

---

Age-Specific Considerations: Elderly Patients

For patients >65 years with pruritus: 1, 8

• Initial treatment: Emollients and topical steroids for at least 2 weeks to exclude asteatotic eczema 1, 8
• Use moisturizers with high lipid content 1, 8
• Gabapentin may be beneficial 8
• Avoid sedative antihistamines due to dementia risk 2
• Consider bullous pemphigoid (may present with pruritus alone before blisters appear)—request skin biopsy and indirect immunofluorescence if suspected 1

---

Referral Criteria

Refer to Dermatology:

• Persistent pruritus >2-4 weeks despite first-line therapy 2, 8
• Diagnostic doubt or rash persists beyond 2 weeks 2, 8
• Primary care management does not relieve symptoms 1, 8

Refer to Hepatology:

• Significant hepatic impairment or persistent elevation of liver enzymes 2, 8

Refer to Nephrology:

• Elevated creatinine requiring dialysis optimization 2, 8

Refer to Hematology:

• Suspected polycythemia vera (elevated hemoglobin/hematocrit with positive JAK2 mutation) 2

Emergency Department Referral (Immediate):

• Hypotension, tachycardia, or respiratory distress 2
• Severe abdominal pain with jaundice 2
• Altered mental status 2
• Rash with fever and mucosal involvement 2

---

Common Clinical Pitfalls and How to Avoid Them

Critical errors to avoid: 1, 2, 8

1. Failing to check comprehensive iron studies in all cases—ferritin alone is insufficient 2, 8
2. Delaying sodium restriction when salt-triggered pruritus is present—this is the most direct intervention 2
3. Assuming antihistamines alone will control systemic pruritus—they are generally ineffective for underlying malignancy or organ-specific causes 2
4. Overlooking scabies, especially in immunocompromised or HIV-positive patients with minimal skin findings 2
5. Delaying bile acid testing when cholestatic disease is suspected 8
6. Ordering extensive thyroid testing without clinical indicators 2, 8
7. Using gabapentin for hepatic pruritus—it is contraindicated and ineffective 2
8. Long-term use of sedating antihistamines in elderly—increases dementia risk 2
9. Failing to conduct thorough medication review—drug-induced pruritus is common and reversible 2
10. Attributing pruritus to psychogenic causes before ruling out physical causes—physical causes must be excluded first 2, 6

---

Primary Care Management Algorithm

Step 1: Immediate actions (Day 1): 1, 8

• Start emollients liberally twice daily 1, 8
• Provide self-care advice 1, 8
• Order mandatory laboratory panel 1, 2, 8
• Complete thorough medication review 2

Step 2: Symptomatic treatment (while awaiting results): 1, 8

• Non-sedating antihistamine trial 1, 8
• Consider topical menthol or clobetasone butyrate 1, 8

Step 3: Follow-up and reassessment: 1, 8

• Review laboratory results when available 2, 8
• Implement cause-specific treatment if etiology identified 1, 2, 8
• Regular follow-up for patients where underlying cause not evident 1

Step 4: Referral decision (if no improvement after 2-4 weeks): 2, 8

• Refer to secondary care if diagnostic doubt or symptoms persist 1, 8